HilleVax, Inc. (HLVX) — Financial statements
Income statement, balance sheet, and cash flow for HilleVax, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00↓100.0% | 2↓4.3% | 2↑74966.7% | 0.00 | 0.00 | |
| Gross Profit | 0.00↑100.0% | -2↑4.3% | -2↓74966.7% | -0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 78↓26.7% | 107↑132.4% | 46↑358.4% | 10 | 0.00 | |
| General & Administrative Expenses | 29↑8.0% | 27↑59.6% | 17↑190.2% | 6↑344.5% | 1 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 29↑8.0% | 27↑59.6% | 17↑190.2% | 6↑344.5% | 1 | |
| Other Expenses | 48 | 0.00↑100.0% | -95 | 0.00 | 0.00 | |
| Operating Expenses | 155↑16.5% | 133↑113.0% | 63↑297.0% | 16↑1117.8% | 1 | |
| Total Costs & Expenses | 0.00↓100.0% | 133↑113.0% | 63↑297.0% | 16↑1117.8% | 1 | |
| Operating Results | ||||||
| Operating Income | -155↓16.5% | -133↓104.8% | -65↓21.9% | -53↓4025.6% | -1 | |
| Depreciation & Amortization | 0.00↓100.0% | 0.88↓61.0% | 2↑74966.7% | 0.00↓99.8% | 1 | |
| EBITDA | -155↓17.2% | -132↓103.4% | -65↑34.6% | -100↓12680.6% | -0.78 | |
| EBIT | -151↓12.9% | -133↓113.0% | -63↑37.1% | -100↓4700.6% | -2 | |
| Interest & Other Income | ||||||
| Net Interest Income | 10↑41.8% | 7↑1486.6% | 0.46↑116.2% | -3↓9706.9% | -0.03 | |
| Interest Income | 7↓27.3% | 10↑150.5% | 4↑136151.8% | 0.00↑9706.9% | 0.00 | |
| Interest Expense | -3↓238.7% | 2↓29.9% | 3↑20.0% | 3↑9706.9% | 0.03 | |
| Non-Operating Income | -5 | 0.00↑100.0% | -3↓105.4% | 46↑5822.7% | 0.78 | |
| Other Income / Expenses | 8↓17.9% | 10↑110.3% | -95↓93.3% | -49↓5962.1% | -0.81 | |
| Income Before Tax | -147↓19.2% | -124↑22.7% | -160↓56.1% | -102↓4769.6% | -2 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -147↓19.2% | -124↑22.7% | -160↓56.1% | -102↓4769.6% | -2 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -147↓19.2% | -124↑51.9% | -257↓202.3% | -85↓3888.0% | -2 | |
| Bottom-Line Net Income | -147↓19.2% | -124↑22.7% | -160↓56.1% | -102↓4769.6% | -2 | |
| EPS (Basic) | -3.00↑1.3% | -3.04↑55.5% | -6.83↓142.2% | -2.82↓3894.3% | -0.07 | |
| EPS (Diluted) | -3.00↑1.3% | -3.04↑55.5% | -6.83↓142.2% | -2.82↓3894.3% | -0.07 | |
| Weighted Average Shares | 49↑21.1% | 41↑7.8% | 38↑24.7% | 30↑0.0% | 30 | |
| Weighted Average Diluted Shares | 49↑21.1% | 41↑7.8% | 38↑24.7% | 30↑0.0% | 30 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.